---
figid: PMC3744053__fonc-03-00211-g005
figlink: /pmc/articles/PMC3744053/figure/F5/
number: Figure 5
caption: Signaling pathways of anti-permeability factors. The most relevant anti-permeability
  factors are angiopoietin-1 (Ang1), sphingosine-1-phosphate (S1P), and fibroblast
  growth factor (FGF). Ang1 activation of its cognate receptor, Tie2, elicits a signaling
  pathway and promotes Src sequestration; thus hindering VEGF-A signaling and VE-cadherin
  internalization. S1P signaling maintains vascular integrity by modulating VE-cadherin
  internalization, cytoskeletal rearrangement, barrier enhancement and integrity,
  through its cognate receptor S1P1R. FGF maintains the integrity of the VE-cadherin/p120-catenin
  complex, thus stabilizing VE-cadherin at the membrane.
pmcid: PMC3744053
papertitle: Vascular Permeability and Drug Delivery in Cancers.
reftext: Sandy Azzi, et al. Front Oncol. 2013;3:211.
pmc_ranked_result_index: '15226'
pathway_score: 0.9734544
filename: fonc-03-00211-g005.jpg
figtitle: Signaling pathways of anti-permeability factors
year: '2013'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3744053__fonc-03-00211-g005.html
  '@type': Dataset
  description: Signaling pathways of anti-permeability factors. The most relevant
    anti-permeability factors are angiopoietin-1 (Ang1), sphingosine-1-phosphate (S1P),
    and fibroblast growth factor (FGF). Ang1 activation of its cognate receptor, Tie2,
    elicits a signaling pathway and promotes Src sequestration; thus hindering VEGF-A
    signaling and VE-cadherin internalization. S1P signaling maintains vascular integrity
    by modulating VE-cadherin internalization, cytoskeletal rearrangement, barrier
    enhancement and integrity, through its cognate receptor S1P1R. FGF maintains the
    integrity of the VE-cadherin/p120-catenin complex, thus stabilizing VE-cadherin
    at the membrane.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGF11
  - FGF10
  - FGF9
  - FGF19
  - FGF12
  - FGF8
  - VEGFA
  - FGF13
  - FGF20
  - FGF7
  - FGF16
  - FGF4
  - FGF5
  - SOAT1
  - FGF6
  - KDR
  - FGFR1
  - FGF22
  - FGF14
  - FGF21
  - FGF3
  - FGF2
  - FGF23
  - FGF17
  - CDH5
  - FGFR2
  - MBTPS1
  - FGFR3
  - FGF1
  - TEK
  - FGFRL1
  - SRC
  - FGF18
  - FGFR4
  - Cancer
genes:
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF11
  entrez: '2256'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF10
  entrez: '2255'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF9
  entrez: '2254'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF19
  entrez: '9965'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF12
  entrez: '2257'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF8
  entrez: '2253'
- word: VEGF-A
  symbol: VEGF-A
  source: hgnc_alias_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF13
  entrez: '2258'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF20
  entrez: '26281'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF7
  entrez: '2252'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF16
  entrez: '8823'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF4
  entrez: '2249'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF5
  entrez: '2250'
- word: a-cat
  symbol: ACAT
  source: hgnc_alias_symbol
  hgnc_symbol: SOAT1
  entrez: '6646'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF6
  entrez: '2251'
- word: VEGF-R2
  symbol: VEGFR2
  source: hgnc_alias_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF22
  entrez: '27006'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF14
  entrez: '2259'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF21
  entrez: '26291'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF3
  entrez: '2248'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF23
  entrez: '8074'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF17
  entrez: '8822'
- word: VE-cadherin
  symbol: CDH5
  source: hgnc_symbol
  hgnc_symbol: CDH5
  entrez: '1003'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: S1P
  symbol: S1P
  source: hgnc_alias_symbol
  hgnc_symbol: MBTPS1
  entrez: '8720'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF1
  entrez: '2246'
- word: Tie2
  symbol: TIE-2
  source: hgnc_alias_symbol
  hgnc_symbol: TEK
  entrez: '7010'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFRL1
  entrez: '53834'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF18
  entrez: '8817'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
